Stan S. Greenberg
- Biochemistry top 2%
- Eicosanoids and Hypertension Pharmacology 23
- Physiology top 5%
- Nitric Oxide and Endothelin Effects 40
-
- Blood Pressure and Hypertension Studies 6
- Cardiac electrophysiology and arrhythmias 6
-
- Neuropeptides and Animal Physiology 7
-
- Cardiac Ischemia and Reperfusion 9
-
- Pulmonary Hypertension Research and Treatments 8
-
- Receptor Mechanisms and Signaling 7
- Co-authors
- Jianming XieF.P.J. DieckeThomas D. GilesKeith J. PeevyJie OuyangXinfang ZhaoJay K. KollsSteve Nelson
- Partner nations
- United StatesGermanySweden
In The Last Decade
Stan S. Greenberg
95 papers receiving 1.4k citations
Peers
Comparison fields: 5 of 114
- Biochemistry 279
- Physiology 778
- Endocrine and Autonomic Systems 125
- Cardiology and Cardiovascular Medicine 401
- Cellular and Molecular Neuroscience 180
Countries citing papers authored by Stan S. Greenberg
This map shows the geographic impact of Stan S. Greenberg's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stan S. Greenberg with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stan S. Greenberg more than expected).
Fields of papers citing papers by Stan S. Greenberg
This network shows the impact of papers produced by Stan S. Greenberg. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stan S. Greenberg. The network helps show where Stan S. Greenberg may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Stan S. Greenberg, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Tolerability profile of cladribine tablets therapy for patients with relapsing-remitting multiple sclerosis: factors contributing to treatment completion overall and in patients with high disease activity in the 96-week CLARITY study | 2011 | 1 |
| 2 | Effects of cladribine tablets on peripheral lymphocyte subtypes implicated in multiple sclerosis immunopathogenesis: surface marker analysis for a subset of patients from the 96-week, phase III, double-blind, placebo-controlled CLARITY study | 2009 | 9 |
| 3 | 1998 | 10 | |
| 4 | 1998 | 1 | |
| 5 | 1996 | 13 | |
| 6 | 1996 | 7 | |
| 7 | 1994 | 14 | |
| 8 | 1993 | 63 | |
| 9 | 1993 | 24 | |
| 10 | 1993 | 28 | |
| 11 | 1991 | 4 | |
| 12 | 1991 | 2 | |
| 13 | 1991 | 29 | |
| 14 | 1990 | 17 | |
| 15 | 1990 | 3 | |
| 16 | 1989 | 62 | |
| 17 | 1988 | 3 | |
| 18 | Prostaglandins, organ- and tissue-specific actions | 1982 | 1 |
| 19 | 1981 | 18 | |
| 20 | 1973 | 19 |
About Stan S. Greenberg
Stan S. Greenberg is a scholar working on Biochemistry, Physiology and Cardiology and Cardiovascular Medicine, having authored 98 papers that have together received 1.5k indexed citations. Recurring topics across this work include Nitric Oxide and Endothelin Effects (40 papers), Eicosanoids and Hypertension Pharmacology (23 papers), Cardiac Ischemia and Reperfusion (9 papers), Pulmonary Hypertension Research and Treatments (8 papers), Neuropeptides and Animal Physiology (7 papers), Receptor Mechanisms and Signaling (7 papers), Blood Pressure and Hypertension Studies (6 papers) and Cardiac electrophysiology and arrhythmias (6 papers). The work is most often cited by research in Biochemistry (279 citations), Physiology (778 citations) and Endocrine and Autonomic Systems (125 citations). Stan S. Greenberg has collaborated with scholars based in United States, Germany and Sweden. Frequent co-authors include Jianming Xie, F.P.J. Diecke, Thomas D. Giles, Keith J. Peevy, Jie Ouyang, Xinfang Zhao, Jay K. Kolls, Steve Nelson, Elinor H. Cantor and Jifang Wang. Their work appears in journals such as Gastroenterology, Circulation Research and The FASEB Journal.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.